Classification
Compound class	Antibody

International Nonproprietary Names
INN number	INN
10121	cabiralizumab

Synonyms

BMS-986227 | FPA-008 | FPA008

Comments

Cabiralizumab is an investigational humanized monoclonal antibody targeting the receptor tyrosine kinase, CSF1R (Fms). It is being investigated for its potential anti-cancer activity. Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US20110274683 [1]

Database Links
Specialist databases
IMGT/mAb-DB	587
Other databases
GtoPdb PubChem SID	315661192
Search PubMed clinical trials	cabiralizumab
Search PubMed titles	cabiralizumab
Search PubMed titles/abstracts	cabiralizumab